Tectonic Therapeutic | AVRO - Ativo Circulante





Ativo Circulante Alterar Data
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Celltrion KRW 5.54T 291.68B 2025-09
Cspc Pharmaceutical CNY 22.61B 721.94M 2025-06
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
Gilead Sciences USD 19.89B 1.05B 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Knight Therapeutics CAD 400.7M 20.57M 2025-09
MacroGenics USD 232.09M 27.15M 2025-09
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 284.9M 7.11M 2025-09
Ovoca Bio EUR 4.96M 2.06M 2022-06
Pfizer USD 46.92B 3.22B 2025-09
Pharma Mar EUR 283.41M 40.53M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.95B 3.09B 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Sartorius EUR 1.72B 449M 2025-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Takeda JPY 3.12T 195.82B 2025-12
Tilray USD 688.63M 2.34M 2025-03
Zz Pientze Pharmaceu CNY 10.7B 1.59B 2025-09